Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2018 Nov 12;8:16680. doi: 10.1038/s41598-018-35080-5

A Lateral Flow Immunochromato-graphic Strip Test for Rapid Detection of Oseltamivir Phosphate in Egg and Chicken Meat

Xingdong Yang 1,2, Jifei Yang 2, Yinbiao Wang 3, Lili Li 1, Zhongke Sun 1, Zonghao Yue 1, Fengshou Tian 1, Le He 1, Xiaofei Hu 2,
PMCID: PMC6232097  PMID: 30420605

Abstract

A lateral flow immunochromatographic strip test (LFIST) based on a competitive format was developed for rapid and sensitive on-site detection of oseltamivir phosphate (OP) residues in poultry product. The sensitivity (half inhibitory concentration, IC50) of the LFIST in the detection of egg and chicken meat samples was confirmed to be 2.56 and 2.63 µg/kg, and the limit detection (LOD) value were 0.43 and 0.42 µg/kg, respectively. For intra-assay and inter-assay reproducibility, recoveries of OP spiked samples ranged between 82.8% and 91.2% with coefficients of variations (CV) less than 5.67% (intra-assay) and 6.52% (inter-assay). The performance of LFIST was comparable to high-performance liquid chromatography (HPLC) in a parallel testing of egg samples and chicken samples. LFIST takes less than 5 minutes, eliminates the dependency on professional personnel, and thus can be used as a surveillance tool for on-site detection of OP residues.

Introduction

Oseltamivir phosphate (OP) is an ethyl ester prodrug widely used to treat and prevent infections from influenza A and B virus1,2. After oral administration, OP is absorbed by the gastrointestinal tract and metabolized into oseltamivir carboxylic acid (OCA) under the action of the liver esterase. OCA is a potent and selective inhibitor of the influenza virus that binds the viral surface protein neuraminidase (NA) and inhibits its activity3,4. The specific inhibition of neuraminidase activity finally prevents the release of virus from infected cells and reduces infection-related symptoms5,6. In China, the use of OP as an antiviral veterinary drug has been banned in livestock and poultry breeding (Bulletin of the Chinese Ministry of Agriculture under Grant 560)7. Nevertheless, OP is still illegally and even excessively used for avian influenza treatment in the poultry industry, especially in chicken farming8,9. OP residues may enter the human body via the food chain and affect human health. Researches showed that exposure to excessive OP can lead to gastrointestinal disturbances10,11, abnormal neuropsychiatric symptoms12,13, and sudden deaths14,15. Therefore, the detection of OP in agriculture and food supply is essential for human health and a surveillance system for monitoring OP residues is required.

To date, several analytical methods for the detection of OP have been reported, including HPLC16,17, ultra-high- performance liquid chromatography-tandem mass spectrometry (UPLC–MS/MS)18,19, and liquid chromatography-mass spectrometry(LC-MS)20. Although these methods are highly accurate and sensitive, they are dependent on expensive analytical instruments, complex pre-treatment steps, and skilled professionals. Moreover, they are not suitable for high-throughput assay and real time on-site detection. On the contrary, LFIST, which utilizes the specific interaction between antibody and antigen in a sandwich format21 or competitive format22, is rapid and easy to be used by non-professionals. LFISTs for the specific detection of bacteria23, viruses24, pesticides25, veterinary drugs2628, toxins29,30 and allergens31,32 have been developed and tested. However, there is no available LFIST for detecting OP currently. Hence, in this study, we prepared a highly specific monoclonal antibodies (mAbs) against OP and developed a LFIST using colloidal gold labelled mAbs as the probe. The LFIST was evaluated in term of sensitivity, specificity, and accuracy by testing OP spiked egg samples and chicken samples. It showed that the LFIST was OP-specific and could provide qualitative results with naked eyes within 5 min and quantitative results with the aid of a strip reader.

Materials and Methods

Reagents, Materials, and Apparatus

OP and OCA were bought from Sigma (St. Louis, MO, USA). 1-(3-(dimethylamino) propyl)-3-ethylcarbodiimide hydrochloricde (EDC) and N-Hydroxy succinimide (NHS) were purchased from Fluka, China. Bovine serum albumin (BSA), ovalbumin (OVA), Freund’s complete adjuvant (FCA) and Freund’s incomplete adjuvant (FIA) were obtained from BDH (VWR International Ltd.). 4-bromobutyric acid ethyl ester and N,N-dimethylformamide (DMF) were bought from Aladdin Chemistry Ltd. (Shanghai, China). BALB/c mice were acquired from the SPF standard Laboratory Animal Center (Zhengzhou University, China) and raised according to the animal Ethics committee of Zhoukou Normal University. All reagents and solvents were of analytical grade or higher in this study.

Thermo Scientific NaoDrop 2000c UV scanner, gel imaging system, and the Multifuge X1R high-speed refrigerated centrifuge were bought from Thermo Scientific (USA). The XYZ Biostrip Dispenser, CM4000 Cutter, and TSR3000 membrane strip reader were purchased from Bio-Dot (Richmond, CA).

Synthesis of Artificial Antigens

Chemical modification of OCA was carried out using the active ester method to prepare OP-BSA and OP-OVA conjugates according to the instruction described by Liu and coauthors with minor modification33, Briefly, 58.0 mg of OCA was mixed with 26.0 mg of NHS, 42.0 mg of EDC and 2 mL of DMF for 6 h at room temperature (RT). Then, the mixture was added into 3.0 mL of PBS dissolving 107.0 mg of BSA and stirred for 12 hours at 4 °C. The above solution was dialyzed against PBS, collected by centrifugation at 1510 × g for 20 min at 4 °C, and then stored at −20 °C. UV scanning was employed to deduce the conjugation ratio of OCA with BSA and OVA.

Preparation of mAbs against OP

Hybridomas secreting anti-OP mAbs were generated according to previously described34. Each BALB/c female mice was subcutaneously immunized with 60 µg OP-BSA (immunogen) in 100 µL immunoadjuvant (the first time with FCA, the rest with FIA) at intervals of 21 days for four times. Serum antibodies and mAbs were collected and detected by indirect and competitive indirect ELISAs. Ascites fluids were produced in paraffin-primed BALB/c mice and IgG was purified using a HiTrap protein A column. Affinity and isotype of the mAbs were characterized using ELISA and a mouse mAbs isotyping kit (Sigma, USA).

Indirect ELISA and Competitive Indirect ELISA

Indirect ELISA was performed as following: 96-well microplates were coated with OP-OVA (coating antigen) in 0.05 M carbonate-bicarbonate buffer (pH 9.6) by incubation at 4 °C overnight. Then the wells were blocked with 5% skimmed milk at 37 °C for 1 h. Two-fold serially diluted serum sample or cell culture supernatant was added and incubated at 37 °C for 30 min. Goat-anti-mouse IgG-HRP conjugate was added and incubated for another 30 min at 37 °C. The optical densities (ODs) were measured at 450 nm with a microplate reader after color development with TMB (3,3′, 5,5;-tetramethylbenzidine) chromogen solution and termination with 2 mol/L H2SO4. The competitive indirect ELISA was carried out as following: microplates were coated as described above, and serially diluted free OP in PBS was then added together with the antibody and incubated for 30 min at 37 °C. The following procedures were identical to those employed in indirect ELISA. During the steps, TBST [TBS containing 0.05% Tween 20 (v/v), pH 7.4] was used as wash buffer to remove unbound antigens or antibodies.

Assembly of the LFIST

Gold was prepared by gold chloride of reduction with 1% sodium citrate (w/v), sodium carbonate (0.2 mol/L) was used to adjust the PH of colloidal gold solution to 8.2. Anti-OP mAbs solution (50 µL) was 2-fold serially diluted in DDW (double distilled water) mixed with 200 µL of colloidal gold solution, and then 200 µL of a 10% sodium chloride solution was added at room temperature to identify the optimum proportion of colloidal gold solution and mAbs solution. After 8 minutes, with the concentration of mAbs decreased, the color of solution changed from brilliant red to blue. The most appropriate concentration of colloidal gold labeling mAbs was the lowest concentration of mAbs solution which color had changed. The treated sample pad, conjugate pad, absorption pad, and NC membrane were assembled according to the previously described steps34 (Fig. 1a).

Figure 1.

Figure 1

(a) Structure diagram of the (LFIST). (b) The visual results determination in test procedure.

Principle of the LFIST

Colloidal gold was prepared and labelled with anti-OP mAbs according to previously described35. Colloidal gold labelled mAbs, OP-BSA conjugate, goat-anti-mouse IgG were respectively dispensed onto the conjugate pad, the test line (T line), and the control line. The pre-treated sample pad, conjugate pad, absorption pad, and NC membrane were assembled according to the previously described steps36. After loading onto the sample pad, the sample solution migrates to the absorbent pad in less than 5 min. If the sample contains OP, free OP in the sample will compete with the OP-BSA on T line for binding gold-labeled mAbs, interfering color developing on the T line. Thus, the concentration of OP in the sample is inversely correlated with the intensity of color on the T line. The control line will always appear as a visible red line, indicating the validation of the test. The test is considered as invalid if no control line appear, and should be done again using a new test strip (Fig. 1b).

Sample Pretreatment for the LFIST

Chicken and egg samples from market were pretreated and tested for the presence of OP by UPLC–MS/MS. Three gram of sample was homogenized in 9 mL of 0.25 mol/L ammonium acetate buffer solution, added 9 ml of a mixture of methanol and acetonitrile (2:1, v/v), vibrated for 12 min, and centrifugated at 3900 × g for 5 min. 2000 µL of the supernatant was evaporated to dryness at 45 °C under a gentle flow of nitrogen gas. The residue was then resuspended in 1000 µL of the mixed solution of PBS and methanol (4:1, V/V), and tested.

Evaluation of the Performance of LFIST

The performance of LFIST was evaluation in terms of sensitivity, specificity, and accuracy. The sensitivity of the LFIST was determined by detection of negative chicken samples spiked with 0.0, 1.0, 2.0, 4.0, 8.0, 16.0, 32.0, 64.0, 128.0, and 256.0 ng/mL of OP. Each sample was tested in triplicate. To obtain the relative optical density (ROD) for constructing a standard curve, color density of the T line was read by a TSR3000 membrane strip reader (Bio-Dot). IC50 was obtained from the linear regression equation.

The specificity of the LFIST was identified by testing its cross-reactivity (CR) with similar competitors to OP including amantadine, moroxydine, Ribavirin, acyclovir, amoxicillin trihydrate, and enrofloxacin. OP, OCA, or the competitors were added to the negative egg samples at a concentration of 1 µg/mL respectively, and tested by LFIST, and the CR were calculated by the equation: CR (%) = (IC50 of OP)/IC50 of the other competitors) × 100%.

To estimate the accuracy, chicken samples containing 5, 10, and 20 µg/kg of OP were tested by LFIST using the same batch of strips (n = 6). For inter-assay precision, three batches of strips were used in LFIST. Accuracy and precision were indicated as recovery and CV, respectively.

Authenticity of LFIST

Egg and chicken samples, containing three different OP concentrations (3.5, 9.7, and 27.9 µg/kg, representing low, medium and high levels of the residues), were detected by LFIST and HPLC, respectively. Results from two methods were compared to the given concentrations by one-sample T test respectively and analyzed by independent-sample T test. The differences between the test values and the relative given concentration were considered statistically significant at P < 0.05.

Results

Preparation of Artificial Antigens and mAbs

The immunogen (OP-BSA) and coating antigen (OP-OVA) in ELISAs were synthesized by coupling free amino groups of the carrier proteins and carboxyl acid group of the OCA using the active ester method (Fig. 2). The conjugation ratio for OP-BSA and OP-OVA were about 18.1:1 and 16.4:1 respectively. After cell fusion and screening with ELISAs, anti-OP mAbs 1D7, 2B3, 2E6, and 4G5 were obtained, and IgG for each mAbs was purified from ascites fluid using protein A column. The titres of 1D7, 2B3, 2E6, and 4G5 were 1:2.56 × 105, 1:1.28 × 105, 1:5.12 × 105 and 1:2.56 × 105, respectively; the affinity constants (Ka) of 1D7, 2B3, 2E6, and 4G5 were 7.96 × 109, 3.24 × 109, 1.80 × 1010, and 8.15 × 109 L/mol, respectively. mAbs 2E6 (IgG1) showed the best IC50 value of 2.35 ng/mL and was selected to be used in the development of LFIST.

Figure 2.

Figure 2

Chemical strutures of the synthetic routes to OP-BSA via the active ester method.

Sensitivity of the LFIST

Sensitivity was determined by testing the responses of LFIST to detect a series of OP spiked samples. Relative optical density (ROD) of the T lines were scanned by a Bio-Dot TSR3000 membrane strip reader. ROD values and OP concentrations in the samples had an inverse relationship as shown for detecting egg samples (Fig. 3a and Table 1) and chicken samples (Fig. 3b and Table 2). In both detections, the G/D × A (area) and G/peak of the ROD decreased with the increase of OP concentration in the samples.

Figure 3.

Figure 3

ROD curves of the egg sample extracts (a) and chicken sample extracts (b). The matrix extracts from negative samples spiked with 0.0, 1.0, 2.0, 4.0, 8.0, 16.0, 32.0, 64.0, 128.0, and 256.0 ng/mL of OP were tested by LFIST and T lines were scanned with a TSR3000 membrane strip reader.

Table 1.

G/Peak and G/D × area of the ROD of T lines from egg samples spiked with OP.

OP concentrations (µg/Kg) G/D × area-ROD (pixel) G/Peak-ROD (pixel)
0 185.7710 0.1081
1 133.3474 0.0855
2 103.9262 0.0612
4 74.1141 0.0445
8 47.2295 0.0291
16 19.1198 0.0122
32 2.4209 0.0070
64 2.2358 0.0035
128 2.1082 0.0029
256 2.0447 0.0027

Table 2.

G/Peak and G/D × area of the ROD of T lines from chicken samples spiked with OP.

OP concentrations (µg/Kg) G/D × area-ROD (pixel) G/peak-ROD (pixel)
0 184.8360 0.1077
1 130.7277 0.0846
2 102.5247 0.0609
4 73.1491 0.0440
8 46.1188 0.0290
16 19.1297 0.0118
32 2.3543 0.0068
64 2.1369 0.0033
128 2.0315 0.0027
256 1.9792 0.0026

The concentration of standard OP and the G/D × area ROD showed a clear linear association within the range of 1–32 ng/mL for egg samples (Fig. 4a) and chicken samples (Fig. 4b). A quantitative calibration curve was drawn by plotting B/B0 percentage of the G/D × area-ROD obtained from the standard samples against the logarithmic concentrations of OP in egg samples or in chicken samples. Based on the regression equations, the calculated IC50 were 2.56 ng/mL (R2 = 0.9943) for testing egg samples and 2.63 ng/mL (R2 = 0.9939) for testing chicken samples. The LOD of LFIST was quantitatively defined as the amount of OP in the standard sample solution that caused a 20% decrease of the G/peak-ROD compared with that produced by the blank sample. The LODs were determined to be 0.43 μg/kg for testing egg samples and 0.42 μg/kg for testing chicken samples. In qualitative testing with naked eyes, the LOD was determined by the minimal amount of OP that produced a clearly visible difference between the T lines for detecting standard samples and negative samples. The LODs in testing egg samples (Fig. 5a) and chicken samples (Fig. 5b) both reached 4 μg/kg by unaided visual assessment.

Figure 4.

Figure 4

Standard curves for detecting egg samples (a) and chicken meat samples (b) using LFIST. The X-axis is shown as the logarithmic concentrations of OP. B/B0 expresses the percentage of ROD of the spiked samples divided by ROD of the negative samples. IC50 for testing each sample were calculated as 2.56 ng/mL (a) and 2.63 ng/mL (b), respectively.

Figure 5.

Figure 5

Qualitative detections of OP in egg samples (a) and chicken samples (b). A serial dilution (0 to 256 ng/mL) of OP was added into the samples and tested by the LFIST. The results were judged with naked eye based on color differences in the T lines.

CR of the LFIST

To identify the specificity of the test, LFIST was used to detect egg samples spiked with OP and other competitors including amantadine, moroxydine, ribavirin, acyclovir, amoxicillin trihydrate, and enrofloxacin doped at a concentration of 1000 µg/kg. It was found that the LFIST gave a 100% CR with OP and oseltamivir carboxylic acid, and less than 0.09% CR with other competitors (Table 3). Thus, LFIST for the detection of OP was highly specific and expressed negligible CR with amantadine, moroxydine, ribavirin, acyclovir, amoxicillin trihydrate, and enrofloxacin.

Table 3.

CR of the LFIST.

Compounds tested IC50 (µg/Kg) CR (%)
Oseltamivir Phosphate 2.56 100
Oseltamivir carboxylic acid 2.56 100
Amantadine >256 <0.09
Moroxydine >3.0 × 103 <0.09
Ribavirin >3.0 × 103 <0.09
Acyclovir >3.0 × 103 <0.09
Amoxicillin trihydrate >3.0 × 103 <0.09
Enrofloxacin >3.0 × 103 <0.09

Recovery of OP in Egg and Chicken Samples

In order to determine the accuracy of the LFIST, egg and chicken samples containing 5, 10, and 20 μg/kg of OP were tested for recovery efficiency. For intraassay recovery, the recoveries ranged from 84.6% to 91.2% with the highest CV at 5.67%. For interassay recovery, the recoveries ranged from 82.8 to 90.6% with the highest CV at 6.52% (Table 4).

Table 4.

Recovery and precision of LFIST for detecting OP spiked in egg and chicken samples.

Spiked OP (µg/kg) Intraassay Interassay
Mean ± SD (µg/kg) Recovery (%) CV (%) Mean ± SD (µg/kg) Recovery (%) CV (%)
Egg samples
5 4.32 ± 0.20 86.4 ± 4.0 4.63 4.38 ± 0.27 87.6 ± 5.4 6.19
10 8.93 ± 0.28 89.3 ± 2.8 3.14 8.67 ± 0.44 86.7 ± 4.4 5.07
20 18.24 ± 0.69 91.2 ± 3.5 3.78 18.09 ± 0.87 90.5 ± 4.3 4.81
Chicken samples
5 4.23 ± 0.24 84.6 ± 4.8 5.67 4.14 ± 0.27 82.8 ± 5.4 6.52
10 8.73 ± 0.35 87.3 ± 3.5 4.01 8.89 ± 0.50 88.9 ± 5.0 5.62
20 18.11 ± 0.77 90.55 ± 3.9 4.25 18.17 ± 0.86 90.6 ± 4.3 4.73

Egg samples and chicken samples spiked with OP at 5, 10, and 20 μg/kg were respectively tested using LFIST. Intraassay precision was evaluated using the same batch of strips in LFIST (n = 6). For interassay precision, three batches of strips were used in LFIST. The recoveries and CV were calculated from triplicate assays in all cases.

Authenticity of LFIST

A comparison between LFIST and HPLC was performed by detecting three different concentration levels of OP (3.5, 9.7, and 27.9 µg/kg). There was no significant difference between the two methods for detecting both egg samples and chicken samples (P > 0.05) as shown in Table 5.

Table 5.

Comparison of LFIST with HPLC for detecting three levels of OP residues in egg and chicken samples.

OP concentrations (µg/kg) LFIST (µg/kg) HPLC (µg/kg)
Egg samples
3.5 3.30 ± 0.15 3.34 ± 0.12
9.7 9.14 ± 0.36 9.29 ± 0.34
27.9 26.72 ± 0.73 26.98 ± 0.53
Chicken samples
3.5 3.28 ± 0.17 3.31 ± 0.13
9.7 8.98 ± 0.47 9.22 ± 0.29
27.9 26.47 ± 0.72 26.66 ± 0.65

Discussion

Although the use of OP as a veterinary drug has been banned, illegal and even excessive use occurs in cases, which poses a threat to public health in developing countries. Customers suffer vomiting, nausea, diarrhea, and abnormal neuropsychiatric symptoms from eating animal-derived food products contaminated with OP. Thus, it is highly desired to develop an easy-to-use diagnostic for detecting OP in food products to strengthen surveillance. Although HPLC, UPLC–MS/MS and LC-MS are highly accurate and sensitive, they rely on expensive analytical instruments and trained personnel, and cannot fulfill the need to detect OP at the point-of-care. On the contrary, LFIST, which is an immunoassay dependent on the interaction between antibody and antigen, is a one-step chromatographic assay that can be performed by customers in the market or at home. Hence, we developed a LFIST for the detection of OP for the first time. The LFIST integrated all the required reagents in a test strip and took less than 5 min to give the result, which could be judged qualitatively with naked eyes or quantitatively with a strip reader.

The key to a successful LFIST is the preparation of monoclonal antibodies with strong specificity and high affinity. The immunogenicity of antigens is crucial to activate the immune system and then stimulate the production of antibodies. As a small molecule drug with a molecular weight of 312.35, OP is a hapten which cannot stimulate the host to produce antibodies. The conjugation of OP with carrier proteins such BSA, OVA, and KLH to form a complete antigen is an essential step for the induction of antibodies to OP after immunization37. In this study, the active metabolite of OP, OCA was coupled with BSA and OVA through the active ester method to prepare the immunogen and coating antigen in ELISAs. The conjugation ratio for OP-BSA and OP-OVA were about 18.1:1 and 16.4:1 respectively. Anti-OP mAbs 2E6, which showed an affinity constant (Ka) of 3.24 × 109 L/mol and an IC50 value of 2.35 ng/mL was screened by indirect and competitive indirect ELISA, and selected for conjugation with colloidal gold to be used as a probe in the development of LFIST.

The LFIST was evaluated in terms of sensitivity, specificity, and recovery by testing OP residues in egg samples and chicken samples. IC50 of the LFIST were confirmed to be 2.56 µg/kg and 2.63 µg/kg in the detection of egg samples and chicken samples respectively, indicating that it was highly sensitive. The LOD were 0.43 µg/kg and 0.42 µg/kg for detecting OP in egg samples and chicken samples respectively, which is sufficient for the detection of OP in these samples. For intra-assay and inter-assay reproducibility, recoveries of OP spiked samples ranged from 84.6% to 91.2% for testing egg samples, and 82.8% to 90.6% for testing chicken samples. CV were 3.14–5.67% and 4.73–6.52% for detecting egg and chicken samples, respectively. No significant difference was found in a parallel testing of egg and chicken samples by HPLC and LFIST.

In summary, we developed a sensitive and specific LFIST for rapid detection of OP residues in chicken and eggs. The LFIST is capable to provide both qualitative and semi-quantitative determination of OP at the point-of-care which makes it a very convenient tool to monitor food safety.

Ethical statement

All mice in the experiment were approved by the animal Ethics committee of Zhoukou Normal University (Approval No. ZKNU-1-2017041601-1001) and in accordance with all applicable institutional and governmental regulations concerning the ethical use of animals. This article does not contain any studies with human participants performed by any of the authors.

Statistics

Te mean ± standard deviation (SD) was calculated and all data were plotted using GraphPad Prism 5.0 (Graphpad, La Jolla, CA, USA).

Acknowledgements

This work was supported by the National Science & Technology Pillar Program of the 12th Five-Year Plan (No. 2014BAD13B05), the Natural Science Foundation of Henan (No. 182300410093), and Henan Province Science and Technology Agency (No. 182102310683) and High-level Talents Research Start-up Funds of Zhoukou Normal University (No. zknuc1501010).

Author Contributions

X.Y. and X.H. conceived of the study, designed the study, and drafted the manuscript; J.Y., X.Y., Z.Y. and L.H. carried out the experiments. Z.S. and L.L. participated in data analysis and the design of the study; X.H., Y.W. and F.T. designed the experiments and reviewed drafts of the paper.

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.McNicholl IR, McNicholl JJ. Neuraminidase inhibitors: Zanamivir and oseltamivir. Ann Pharmacother. 2001;35:57–70. doi: 10.1345/aph.10118. [DOI] [PubMed] [Google Scholar]
  • 2.Al-Bagary RI, El-Zaher AA, Morsy FA, Fouad MM. Kinetic Study of the Alkaline Degradation of Oseltamivir Phosphate and Valacyclovir Hydrochloride using Validated Stability Indicating HPLC. Anal Chem Insights. 2014;9:41–48. doi: 10.4137/ACI.S13878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Collins Patrick J., Haire Lesley F., Lin Yi Pu, Liu Junfeng, Russell Rupert J., Walker Philip A., Skehel John J., Martin Stephen R., Hay Alan J., Gamblin Steven J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature. 2008;453(7199):1258–1261. doi: 10.1038/nature06956. [DOI] [PubMed] [Google Scholar]
  • 4.Wang K, et al. Synthesis and biological evaluation of NH2-acyl oseltamivir analogues as potent neuraminidase inhibitors. Eur J Med Chem. 2017;141:648–656. doi: 10.1016/j.ejmech.2017.10.004. [DOI] [PubMed] [Google Scholar]
  • 5.Li Y, et al. Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus. Int J Nanomed. 2017;12:5733–5743. doi: 10.2147/IJN.S140939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Li Y, et al. Silver nanoparticles based co-delivery of Oseltamivir to inhibit the activity of H1N1 influenza virus through ROS-mediated signaling pathways. ACS Appl Mater Interfaces. 2016;8:24385–24393. doi: 10.1021/acsami.6b06613. [DOI] [PubMed] [Google Scholar]
  • 7.Wu S, et al. Development of a competitive immunochromatographic assay for the sensitive detection of amantadine in chicken muscle. Food Chem. 2017;232:770–776. doi: 10.1016/j.foodchem.2017.04.058. [DOI] [PubMed] [Google Scholar]
  • 8.Cyranoski D. China’s chicken farmers under fire for antiviral abuse. Nature. 2005;435:1009. doi: 10.1038/4351009a. [DOI] [PubMed] [Google Scholar]
  • 9.Gillman A, et al. Oseltamivir Resistance in Influenza A(H6N2) Caused by an R292K Substitution in Neuraminidase Is Not Maintained in Mallards without Drug Pressure. PLoS One. 2015;10:e0139415. doi: 10.1371/journal.pone.0139415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Dalvi PS, Singh A, Trivedi HR, Mistry SD, Vyas BR. Adverse drug reaction profile of oseltamivir in children. J Pharmacol Pharmacother. 2011;2:100–103. doi: 10.4103/0976-500X.81901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dutkowski Regina, Thakrar Bharat, Froehlich Enrico, Suter Pia, Oo Charles, Ward Penny. Safety and Pharmacology of Oseltamivir in Clinical Use. Drug Safety. 2003;26(11):787–801. doi: 10.2165/00002018-200326110-00004. [DOI] [PubMed] [Google Scholar]
  • 12.Freichel C, et al. Absence of central nervous system and hypothermic effects after single oral administration of high doses of oseltamivir in the rat. Basic Clin Pharmacol Toxicol. 2012;111:50–57. doi: 10.1111/j.1742-7843.2012.00861.x. [DOI] [PubMed] [Google Scholar]
  • 13.Morimoto K, et al. Analysis of a child who developed abnormal neuropsychiatric symptoms after administration of oseltamivir: a case report. BMC Neurol. 2015;15:130. doi: 10.1186/s12883-015-0393-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hama R. Oseltamivir’s adverse reactions: Fifty sudden deaths may be related to central suppression. BMJ. 2007;335:59. doi: 10.1136/bmj.39262.448877.BE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hama R, Bennett CL. The mechanisms of sudden-onset type adverse reactions to oseltamivir. Acta Neurol Scand. 2017;135:148–160. doi: 10.1111/ane.12629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis. 2008;14:552–556. doi: 10.3201/eid1404.061199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Liu Z, Yang F, Yao M, Lin Y, Su Z. Simultaneous determination of antiviral drugs in chicken tissues by ultra high performance liquid chromatography with tandem mass spectrometry. J. Sep. Sci. 2015;38:1784–1793. doi: 10.1002/jssc.201401461. [DOI] [PubMed] [Google Scholar]
  • 18.Mu P, et al. Simultaneous determination of 14 antiviral drugs and relevant metabolites in chicken muscle by UPLC–MS/MS after QuEChERS preparation. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1023–1024:17–23. doi: 10.1016/j.jchromb.2016.04.036. [DOI] [PubMed] [Google Scholar]
  • 19.Wu H, et al. Development and application of an in-cell cleanup pressurized liquid extraction with ultra-high-performance liquid chromatography-tandem mass spectrometry to detect prohibited antiviral agents sensitively in livestock and poultry feces. J Chromatogr A. 2017;1488:10–16. doi: 10.1016/j.chroma.2017.01.070. [DOI] [PubMed] [Google Scholar]
  • 20.Boberg M, et al. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants. Drug Metab Dispos. 2017;45:216–223. doi: 10.1124/dmd.116.072652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wang Y, et al. Rapid and sensitive detection of the food allergen glycinin in powdered milk using a lateral flow colloidal gold immunoassay strip test. J. Agric. Food Chem. 2015;63:2172–2178. doi: 10.1021/jf5052128. [DOI] [PubMed] [Google Scholar]
  • 22.Sun Y, et al. Development of an immunochromatographic test strip for simultaneous qualitative and quantitative detection of ochratoxin A and zearalenone in cereal. J Sci Food Agric. 2016;96:3673–3678. doi: 10.1002/jsfa.7550. [DOI] [PubMed] [Google Scholar]
  • 23.Schenk F, et al. Development of a paper-based lateral flow immunoassay for simultaneous detection of lipopolysaccharides of Salmonella serovars. Anal Bioanal Chem. 2018;410:863–868. doi: 10.1007/s00216-017-0643-9. [DOI] [PubMed] [Google Scholar]
  • 24.Vrublevskaya VV, et al. A sensitive and specific lateral flow assay for rapid detection of antibodies against glycoprotein B of Aujeszky’s disease virus. J Virol Methods. 2017;249:175–180. doi: 10.1016/j.jviromet.2017.09.012. [DOI] [PubMed] [Google Scholar]
  • 25.Shu Q, et al. Multiplexed immunochromatographic test strip for time-resolved chemiluminescent detection of pesticide residues using a bifunctional antibody. Biosens Bioelectron. 2017;87:908–914. doi: 10.1016/j.bios.2016.09.057. [DOI] [PubMed] [Google Scholar]
  • 26.Byzova NA, Zvereva EA, Zherdev AV, Eremin SA, Dzantiev BB. Rapid pretreatment-free immunochromatographic assay of chloramphenicol in milk. Talanta. 2010;81:843–848. doi: 10.1016/j.talanta.2010.01.025. [DOI] [PubMed] [Google Scholar]
  • 27.Wu Y, Guo S, Dong Q, Song Y. Development of an Immunochromatographic Test Strip for Rapid Simultaneous Detection of Enrofloxacin and Ofloxacin in Tissue of Chicken Muscle and Pork. Food Anal. Methods. 2016;9:2807–2813. doi: 10.1007/s12161-016-0474-x. [DOI] [Google Scholar]
  • 28.Chen Y, et al. Ultrasensitive Immunochromatographic Strip for Fast Screening of 27 Sulfonamides in Honey and Pork Liver Samples Based on a Monoclonal Antibody. J. Agric. Food Chem. 2017;65:8248–8255. doi: 10.1021/acs.jafc.7b03190. [DOI] [PubMed] [Google Scholar]
  • 29.Hu X, Zhang G. An Immunochromatographic Test Strip to Detect Ochratoxin A and Zearalenone Simultaneously. Methods Mol Biol. 2017;1600:95–105. doi: 10.1007/978-1-4939-6958-6_9. [DOI] [PubMed] [Google Scholar]
  • 30.Yao J, et al. Colloidal gold-McAb probe-based rapid immunoassay strip for simultaneous detection of fumonisins in maize. J Sci Food Agric. 2017;97:2223–2229. doi: 10.1002/jsfa.8032. [DOI] [PubMed] [Google Scholar]
  • 31.Wang Y, et al. Establishment of a Lateral Flow Colloidal Gold Immunoassay Strip for the Rapid Detection of Soybean Allergen β-Conglycinin. Food Anal Method. 2017;10:2429–2435. doi: 10.1007/s12161-017-0800-y. [DOI] [Google Scholar]
  • 32.Anfossi L, et al. A lateral flow immunoassay for straightforward determination of fumonisin mycotoxins based on the quenching of the fluorescence of CdSe/ZnS quantum dots by gold and silver nanoparticles. Mikrochim Acta. 2018;185:94. doi: 10.1007/s00604-017-2642-0. [DOI] [PubMed] [Google Scholar]
  • 33.Liu L, et al. Development of an immunochromatographic strip test for rapid detection of ciprofloxacin in milk samples. J. Agric. Sensors (Basel). 2014;14:16785–16798. doi: 10.3390/s140916785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Yang X, et al. Establishment of a lateral flow colloidal gold immunoassay strip for the rapid detection of estradiol in milk samples. LWT-Food Sci Technol. 2015;64:88–94. doi: 10.1016/j.lwt.2015.04.022. [DOI] [Google Scholar]
  • 35.Zhang G, Guo J, Wang X. Immunochromatographic lateral flow strip tests. Methods Mol Biol. 2009;504:169–183. doi: 10.1007/978-1-60327-569-9_12. [DOI] [PubMed] [Google Scholar]
  • 36.Song C, et al. Development of a lateral flow colloidal gold immunoassay strip for the rapid detection of olaquindox residues. J. Agric. Food Chem. 2011;59:9319–9326. doi: 10.1021/jf202213m. [DOI] [PubMed] [Google Scholar]
  • 37.Limsuwanchote Supattra, Putalun Waraporn, Tanaka Hiroyuki, Morimoto Satoshi, Keawpradub Niwat, Wungsintaweekul Juraithip. Development of an immunochromatographic strip incorporating anti-mitragynine monoclonal antibody conjugated to colloidal gold for kratom alkaloids detection. Drug Testing and Analysis. 2018;10(7):1168–1175. doi: 10.1002/dta.2354. [DOI] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES